Clearside Biomedical names Leslie Zacks as general counsel, chief compliance officer

clearside.jpg

Clearside Biomedical (NASDAQ:CLSD) appointed Leslie Zacks, a registered patent attorney, as general counsel and chief compliance officer.

In a legal career spanning more than 24 years, Mr. Zacks most recently served as VP, general counsel and chief compliance officer at Arbor Pharmaceuticals, where he provided strategic counsel on legal, intellectual property and compliance issues. Prior to joining Arbor, Mr. Zacks was EVP, general counsel and chief compliance officer at Shionogi Pharma.

“His appointment comes at a particularly important time, as we prepare to submit our first NDA before the end of this year and continue to advance our late-stage pipeline,” Daniel White, president and CEO of Clearside, said in a statement.

“Leslie’s expertise in navigating the legal and regulatory requirements for the development and commercialization of new products, combined with his established record for developing effective strategies that mitigate risk and enhance business value, will be a tremendous asset for us going forward as we continue to plan Clearside’s transition from a clinical-stage to a commercial-stage company,” he added.

Michelle Carr